Change In Deferred Tax represents future tax liability or asset, resulting from temporary differences between book (accounting) value of assets and liabilities, and their tax value. This arises due to differences between financial accounting for shareholders and tax accounting.
Corcept Therapeutics's change in deferred tax for the
three
months ended in
Dec. 2020 was
$2.3 Mil. Its change in deferred tax for the
trailing twelve months (TTM) ended in
Dec. 2020 was
$14.1 Mil.
Corcept Therapeutics Deferred Tax Calculation
Change In Deferred Tax represents future tax liability or asset, resulting from temporary differences between book (accounting) value of assets and liabilities, and their tax value. This arises due to differences between financial accounting for shareholders and tax accounting.
Deferred Tax for the trailing twelve months (TTM) ended in Dec. 2020 was 5.095 (Mar. 2020 ) + 4.922 (Jun. 2020 ) + 1.761 (Sep. 2020 ) + 2.311 (Dec. 2020 ) = $14.1 Mil.
* All numbers are in millions except for per share data and ratio. All numbers are indicated in the company's associated stock exchange currency.
Corcept Therapeutics Deferred Tax Headlines
Excel Add-In GURUF
API
My Portfolios
Create New Portfolio
Portfolio Contest
My Gurus
Personalize
My Gurus
0.17(0.73%) Volume: 164,497 3:19PM EDT
Email Alerts
Stock PDF
RSS
Website
Filings
Manual of Stocks™ Web APP
NAS:CORT has been successfully added to your 
